Three-Month Marketing Exclusivity Proposed For UK First-In-Class Switches
This article was originally published in The Tan Sheet
Executive Summary
A drug sponsor that is the first to successfully switch an ingredient from Rx to nonprescription status in the UK would receive 90 days of marketing exclusivity under a Medicines Control Agency proposal
You may also be interested in...
UK Drug Reclassification System May Double OTC Switches – Health Minister
The British government expects its new drug reclassification system to potentially double the number of medicines that switch from prescription to non-Rx status
UK Drug Reclassification System May Double OTC Switches – Health Minister
The British government expects its new drug reclassification system to potentially double the number of medicines that switch from prescription to non-Rx status
UK Drug Reclassification System May Double OTC Switches – Health Minister
The British government expects its new drug reclassification system to potentially double the number of medicines that switch from prescription to non-Rx status